|Grant Affiliation:||Weiss: Protection by Neutralizing Antibodies|
|Strategy:||Combo: DNA, protein & VLP vaccines|
|Study Type:||Pre-Clinical Non-NHP|
|Study Start Date:||2011-04-12|
|Study Made Public:||2011-08-08|
The induction of neutralising antibodies to HIV env proteins by modifications to gp41.
CAVD 314 is a preclinical rabbit study investigating several prime-boost regimens in which HIV env gp160 protein and modified gp41 constructs were boosted with virus-like particles containing the corresponding modified gp41 proteins.
Sign in to see full information about this study and to download study data.